BRENDA O'HAIR: Open Payments
NPI 1386617504 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 30 payments from 12 companies in 2025. Trend: 2023 $758 · 2024 $991 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 9 | $231 |
| GENZYME CORPORATION | 3 | $122 |
| Janssen Biotech, Inc. | 3 | $78 |
| Botanix SB Inc | 3 | $64 |
| Organon LLC | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 3 | $45 |
| Galderma Laboratories, L.P. | 2 | $34 |
| Verrica Pharmaceuticals Inc. | 1 | $25 |
| UCB, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: ADBRY, DUPIXENT, TREMFYA, SOFDRA, VTAMA, Zoryve, YCANTH, Bimzelx.
Industry payments across FL — which companies pay providers there.
